ID   CHO SSF3GR
AC   CVCL_E4HT
SY   SSF3GR
RX   PubMed=10516577;
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:7978; NR3C1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P0A9M5; Escherichia coli gpt.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_E4HJ ! CHO SSF3
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 19-12-24; Last updated: 19-12-24; Version: 1
//
RX   PubMed=10516577; DOI=10.1002/(SICI)1097-0290(19991205)65:5<523::AID-BIT4>3.0.CO;2-6;
RA   Gandor C.R., Zang-Gandor M.O., Flor P.J., Marangi M.,
RA   Asselbergs F.A.M.;
RT   "Conditionally adherent growth of serum-independent CHO cells for
RT   automated drug screening and biopharmaceutical production.";
RL   Biotechnol. Bioeng. 65:523-528(1999).
//